2 min read
Adjuvanted influenza vaccine is a cost-effective investment for older adults in the Netherlands
Replacing standard-dose with adjuvanted influenza vaccination in adults aged 60 and over, and in high-risk adults aged 50–59, could prevent hundreds of hospitalisations and deaths per season, at an incremental cost well within accepted Dutch...
Read More